Selective IL-13 inhibitors for the treatment of atopic dermatitis
Background: Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases worldwide. AD pathogenesis is multifactorial, involving environmental and genetic factors. IL-13 stands out as one of the main cytokines in the pathophysiology of AD. Currently, dupilumab, which targets b...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
BioExcel Publishing Ltd,
2021-03-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|